Study of LM-102 in Subjects in Advanced Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: Drug：LM-102
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- LaNova Medicines Limited
- Target Recruit Count
- 9
- Registration Number
- NCT04735796
- Locations
- 🇺🇸
Sarcoma Oncology Research Center, Cancer Center of Southern California, California City, California, United States
🇺🇸Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸Henry Ford Cancer Institute, Detroit, Michigan, United States
Study of LM-061 in Subjects in Advanced Tumors
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- LaNova Medicines Limited
- Target Recruit Count
- 18
- Registration Number
- NCT04737122
- Locations
- 🇦🇺
St George Private Hospital, Kogarah, New South Wales, Australia